MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term marketable
securities
$561,794K
Cash and cash
equivalents
$176,032K
Prepaid expenses and
other current assets
$16,709K
Total current assets
$754,535K
Long-term marketable
securities
$250,490K
Right of use asset
$552K
Total assets
$1,005,577K
Total liabilities and
stockholders' equity
$1,005,577K
Total stockholders'
equity
$957,637K
Total liabilities
$47,940K
Accumulated deficit
-$1,048,952K
Additional paid-in capital
$2,004,755K
Total current
liabilities
$47,651K
Operating lease
liability, noncurrent
$289K
Accumulated other
comprehensive income
$1,826K
Common stock, 0.0001
par value,...
$8K
Accrued expenses and
other current...
$27,252K
Accounts payable
$20,399K
Back
Back
Balance Sheet
source: myfinsight.com
Akero Therapeutics, Inc. (AKRO)
Akero Therapeutics, Inc. (AKRO)